KHK4951

· Kyowa Kirin Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KHK4951, covering 2025-10-30 to 2025-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema [Phase 2]